Altre lingue Eiger BioPharmaceuticals, Inc.

Azioni

EIGR

US28249U2042

Mercato chiuso - OTC Markets Altri mercati azionari 21:58:31 05/07/2024			Variaz. 5gg	Var. 1 gen.
11,29 ^USD	+0,80%		-10,75%	+67,63%

21/06	Amylyx acquisterà il farmaco sperimentale di Eiger per il trattamento della glicemia bassa, in fallimento	RE
08/05	Sentynl Therapeutics, Inc. ha acquisito i diritti globali di Zokinvy da Eiger BioPharmaceuticals, Inc. (OTCPK:EIGR.Q) per 45,2 milioni di dollari.	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar	21/06
Sentynl Therapeutics, Inc. acquired Global rights to Zokinvy Eiger BioPharmaceuticals, Inc. (OTCPK:EIGR.Q) for $45.2 million.	08/05
Sentynl Therapeutics Announces Global Acquisition of Zokinvy for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals	06/05
Zydus Lifesciences Arm Acquires Eiger BioPharmaceuticals' Progeria Drug	06/05
Eiger Biopharmaceuticals, Inc. Announces Resignation of William G. Kachioff as Chief Financial Officer	02/05
Eiger Biopharmaceuticals, Inc. Appoints Douglas Staut to Serve as the Company's Chief Restructuring Officer	02/05
Motion for Asset Sale Approved for Eiger BioPharmaceuticals, Inc.	24/04
Selection of Successful Bidder Filed by Eiger BioPharmaceuticals, Inc.	19/04
Eiger BioPharmaceuticals, Inc.(NasdaqGM:EIGR) dropped from NASDAQ Composite Index	10/04
Eiger BioPharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/04
Bidding Procedure Approved for Eiger BioPharmaceuticals, Inc.	05/04
Motion for Joint Administration Approved for Eiger BioPharmaceuticals, Inc.	05/04
Eiger BioPharmaceuticals, Inc.(NasdaqGM:EIGR) dropped from S&P TMI Index	04/04
Eiger BioPharmaceuticals, Inc. Announces Resignation of Jeffrey S. Glenn as Member of the Board of Directors	03/04
Health Care Down as Obesity-Drug Optimism Fades -- Health Care Roundup	01/04
Sector Update: Health Care Stocks Slide Late Afternoon	01/04
Top Midday Decliners	01/04
Sector Update: Health Care	01/04
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection; Shares Fall	01/04
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection	01/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Eiger BioPharmaceuticals, Inc.

Azioni

EIGR

US28249U2042

Altre lingue

Filtri